Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CURIS INC Director's Dealing 2015

Jan 28, 2015

34952_dirs_2015-01-28_c60f1338-4437-48eb-8798-c269fa0683da.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CURIS INC (CRIS)
CIK: 0001108205
Period of Report: 2015-01-18

Reporting Person: Aurigene Discovery Technologies Ltd (10% Owner)
Reporting Person: DR REDDYS LABORATORIES LTD (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, par value $0.01 per share 17120131 Direct

Footnotes

F1: This Form 3 is being filed jointly by (i) Aurigene Discovery Technologies Limited ("Aurigene"), which directly holds 17,120,131 shares of Common Stock of the Issuer (the "Reported Securities"), and (ii) Dr. Reddy's Laboratories Ltd. ("DRL"), as the parent company and 100% owner of Aurigene.

F2: The filing of this Form 3 shall not be deemed an admission for the purposes of Section 16 or any other purpose that any reporting person is the beneficial owner of any Reported Securities.